Mauna Kea Appoints Joseph DeVivo Director
Joseph M. DeVivo, president and CEO of AngioDynamics Inc., will join the five-member board of directors of Mauna Kea Technologies SA as an independent nonexecutive director.
DeVivo has 20 years of experience as a medical device executive with expertise in the surgical market. He began his career with U.S. Surgical Corp. in sales, marketing and R&D positions, and later served as president of Computer Motion Inc. He was also formerly president and CEO of RITA Medical Systems; global president of Smith & Nephew Orthopaedics; and, in 2011, was named president and CEO at AngioDynamics.
DeVivo also sits on the board of the Advanced Medical Technology Association and chairs the board of SurgicQuest Inc.
Mauna Kea's flagship product, Cellvizio, is a multidisciplinary confocal laser endomicroscopy platform. For more information, visit
www.maunakeatech.com.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024